Chemoinformaics analysis of 5-FERULOYLQUINIC-ACID
| Molecular Weight | 191.186 | nRot | 2 |
| Heavy Atom Molecular Weight | 182.114 | nRig | 11 |
| Exact Molecular Weight | 191.058 | nRing | 2 |
| Solubility: LogS | -1.812 | nHRing | 1 |
| Solubility: LogP | 1.16 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 26.2071 |
| nHD | 3 | BPOL | 10.4669 |
| QED | 0.673 |
| Synth | 2.054 |
| Natural Product Likeliness | 0.386 |
| NR-PPAR-gamma | 0.935 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.012 |
| CACO-2 | -4.829 |
| MDCK | 0.00000421 |
| BBB | 0.093 |
| PPB | 0.664801 |
| VDSS | 0.357 |
| FU | 0.235705 |
| CYP1A2-inh | 0.131 |
| CYP1A2-sub | 0.106 |
| CYP2c19-inh | 0.067 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.968 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.498 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.073 |
| CL | 11.772 |
| T12 | 0.934 |
| hERG | 0.023 |
| Ames | 0.075 |
| ROA | 0.857 |
| SkinSen | 0.537 |
| Carcinogencity | 0.121 |
| EI | 0.771 |
| Respiratory | 0.282 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.733591 |